HOME

SNTA - Synta Pharmaceuticals Corp

Read the Synta Pharmaceuticals Corp company profile. See stock information, press releases, and the latest Tweets on Twitter. The Synta Pharmaceuticals Corp is a company listed in New York NASDAQ.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

SNTA - Synta Pharmaceuticals Corp

Synta Pharmaceuticals Corp., incorporated in March 2000, is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and improve the lives of patients with medical conditions The Company have three clinical-stage drug candidates and several drug candidates in the preclinical and discovery stages. It retains all the dr","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

Synta Pharmaceuticals Corp on Twitter


Abaxis Inc News


Hot Stocks (Synta Pharmaceuticals Corp, Optimer Pharmaceuticals, Comstock ...
SBWire (press release) - May 17, 2013
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) shares fell 7.07% to $7.49. The company, on April 30, provided clinical updates and reported financial results for the first quarter ended March 31, 2013.

SYNTA PHARMACEUTICALS CORP. : Synta Announces Presentations at the ...
4-traders (press release) - May 15, 2013
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic ...

Bridgepoint Education Inc (NYSE:BPI) up by 3.31%, Synta Pharmaceuticals ...
NIS - May 16, 2013
Synta Pharmaceuticals Corp (NASDAQ:SNTA): Wednesday's trading session saw Synta Pharmaceuticals Corp (NASDAQ:SNTA) climbing up by 0.88%.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Perrigo Co. (NASDAQ:PRGO ...
SBWire (press release) - May 8, 2013
New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Perrigo Co. (NASDAQ:PRGO), and Amgen Inc. (NASDAQ:AMGN).

SYNTA PHARMACEUTICALS CORP. : Synta Provides Clinical Updates and ...
4-traders (press release) - Apr 30, 2013
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic ...
Synta Pharmaceuticals Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet

Volume in Focus: Synta Pharmaceuticals Corp.(NASDAQ:SNTA), Suntech ...
SBWire (press release) - May 9, 2013
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) shares fell 13.38% to $6.86. The company, on April 30, provided clinical updates and reported financial results for the first quarter ended March 31, 2013.
Small Cap Stocks in Focus - Fusion-IO, Inc. (NYSE:FIO), Resolute Energy Corp ... - Techsonian (press release)
5 Small-Cap Stocks Look Unappealing: Fusion-IO (NYSE:FIO), Resolute Energy ... - REM

SYNTA PHARMACEUTICALS CORP. : Synta Announces First Patients Treated ...
4-traders (press release) - Apr 22, 2013
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that the first patients have been treated in the randomized GALAXY-2 Phase 3 trial designed to evaluate docetaxel plus ganetespib, its investigational Hsp90 inhibitor, versus docetaxel alone ...

NASDAQ Decliners Watch List: Synta Pharmaceuticals Corp. (NASDAQ:SNTA ...
SBWire (press release) - Apr 23, 2013
NASDAQ Decliners Watch List: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Atossa Genetics, Inc. (NASDAQ:ATOS), and STEC, Inc. (NASDAQ:STEC) Added to Growing Stock Report's NASDAQ Decliners ...

Synta Pharmaceuticals Rating Lowered to Market Perform at BMO Capital ...
Zolmax - May 9, 2013
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and improve the lives of patients with medical conditions The Company have three clinical-stage drug ...

Hospira's former chief scientific officer returns
Businessweek - May 14, 2013
Ramachandra, 44, had left Hospira in March to be president of research and development at biopharmaceutical company Synta Pharmaceuticals Corp. According to a Securities and Exchange Commission filing, Ramachandra left the Lexington, Mass., ...



Next Company >>